Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ernst ter Haar

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Structure (London, England : 1993)|June 7, 2003
Activating MAP KAP kinase 2Ernst ter Haar
The Journal of Biological Chemistry|January 27, 2007
Crystal structure of the p38 alpha-MAPKAP kinase 2 heterodimerErnst Ter Haar, Prakash Prabakhar, Xun Liu, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2010
3-Aryl-4-(arylhydrazono)-1H-pyrazol-5-ones: Highly ligand efficient and potent inhibitors of GSK3betaMichael Arnost, Al Pierce, Ernst ter Haar, et al.
Journal of Medicinal Chemistry|February 18, 2005
CH...O and CH...N hydrogen bonds in ligand design: a novel quinazolin-4-ylthiazol-2-ylamine protein kinase inhibitorAlbert C Pierce, Ernst ter Haar, Hayley M Binch, et al.
The Journal of Biological Chemistry|August 13, 2002
Structure of mitogen-activated protein kinase-activated protein (MAPKAP) kinase 2 suggests a bifunctional switch that couples kinase activation with nuclear exportWuyi Meng, Lora L Swenson, Matthew J Fitzgibbon, et al.
Structure (London, England : 1993)|September 10, 2010
Crystal structure of the ectodomain complex of the CGRP receptor, a class-B GPCR, reveals the site of drug antagonismErnst ter Haar, Christopher M Koth, Norzehan Abdul-Manan, et al.
Proteins|January 13, 2016
Insights into regioselective metabolism of mefenamic acid by cytochrome P450 BM3 mutants through crystallography, docking, molecular dynamics, and free energy calculationsLuigi Capoferri, Rasmus Leth, Ernst ter Haar, et al.
Bioorganic & Medicinal Chemistry Letters|October 22, 2008
Discovery and SAR of novel 4-thiazolyl-2-phenylaminopyrimidines as potent inhibitors of spleen tyrosine kinase (SYK)Luc J Farmer, Guy Bemis, Shawn D Britt, et al.
Journal of Medicinal Chemistry|July 8, 2016
Fragment-Based Discovery of Dual JC Virus and BK Virus Helicase InhibitorsDominique Bonafoux, Suganthini Nanthakumar, Upul K Bandarage, et al.
Journal of Medicinal Chemistry|October 16, 2009
Structure-guided design of potent and selective pyrimidylpyrrole inhibitors of extracellular signal-regulated kinase (ERK) using conformational controlAlex M Aronov, Qing Tang, Gabriel Martinez-Botella, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Structure (London, England : 1993)|June 7, 2003
Activating MAP KAP kinase 2Ernst ter Haar
The Journal of Biological Chemistry|January 27, 2007
Crystal structure of the p38 alpha-MAPKAP kinase 2 heterodimerErnst Ter Haar, Prakash Prabakhar, Xun Liu, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2010
3-Aryl-4-(arylhydrazono)-1H-pyrazol-5-ones: Highly ligand efficient and potent inhibitors of GSK3betaMichael Arnost, Al Pierce, Ernst ter Haar, et al.
Journal of Medicinal Chemistry|February 18, 2005
CH...O and CH...N hydrogen bonds in ligand design: a novel quinazolin-4-ylthiazol-2-ylamine protein kinase inhibitorAlbert C Pierce, Ernst ter Haar, Hayley M Binch, et al.
The Journal of Biological Chemistry|August 13, 2002
Structure of mitogen-activated protein kinase-activated protein (MAPKAP) kinase 2 suggests a bifunctional switch that couples kinase activation with nuclear exportWuyi Meng, Lora L Swenson, Matthew J Fitzgibbon, et al.
Structure (London, England : 1993)|September 10, 2010
Crystal structure of the ectodomain complex of the CGRP receptor, a class-B GPCR, reveals the site of drug antagonismErnst ter Haar, Christopher M Koth, Norzehan Abdul-Manan, et al.
Proteins|January 13, 2016
Insights into regioselective metabolism of mefenamic acid by cytochrome P450 BM3 mutants through crystallography, docking, molecular dynamics, and free energy calculationsLuigi Capoferri, Rasmus Leth, Ernst ter Haar, et al.
Bioorganic & Medicinal Chemistry Letters|October 22, 2008
Discovery and SAR of novel 4-thiazolyl-2-phenylaminopyrimidines as potent inhibitors of spleen tyrosine kinase (SYK)Luc J Farmer, Guy Bemis, Shawn D Britt, et al.
Journal of Medicinal Chemistry|July 8, 2016
Fragment-Based Discovery of Dual JC Virus and BK Virus Helicase InhibitorsDominique Bonafoux, Suganthini Nanthakumar, Upul K Bandarage, et al.
Journal of Medicinal Chemistry|October 16, 2009
Structure-guided design of potent and selective pyrimidylpyrrole inhibitors of extracellular signal-regulated kinase (ERK) using conformational controlAlex M Aronov, Qing Tang, Gabriel Martinez-Botella, et al.
Pageof 1